Skip to main content

Advertisement

SpringerLink
Log in

Postoperative Infectious Morbidity for Resectable Gastric Cancer—Searching Robust Predictors of Survival

  • Gastrointestinal Oncology
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Kappas AM, Roukos DH. Quality of surgery determinant for the outcome of patient with gastric cancer. Ann Surg Oncol. 2002;9:828–30.

    Article  PubMed  Google Scholar 

  2. Roukos DH, Paraschou P, Lorenz M. Distal gastric cancer and extensive surgery : a new evaluation method based on the study of the status of residual lymph nodes after limited surgery. Ann Surg Oncol. 2000;7(10):719–26.

    Article  PubMed  CAS  Google Scholar 

  3. Roukos DH. Innovative genomic-based model for personalized treatment of gastric cancer: integrating current standards and new technologies. Expert Rev Mol Diagn. 2008;8:29–39.

    Article  PubMed  CAS  Google Scholar 

  4. Roukos DH. Assessing both genetic variation (SNPs/CNVs) and interactions with the environment for personalized gastric cancer prevention. Expert Rev Mol Diagn. 2009;9:1–6.

    Article  PubMed  CAS  Google Scholar 

  5. Liakakos T, Roukos DH. More controversy than ever—challenges and promises towards personalized treatment of gastric cancer. Ann Surg Oncol. 2008;15:956–60.

    Article  PubMed  Google Scholar 

  6. Roukos DH. HER2 and response to paclitaxel in node-positive breast cancer. N Engl J Med. 2008;358:197.

    Article  PubMed  CAS  Google Scholar 

  7. Tsujimoto H, Ichikura T, Ono S, et al. Impact of postoperative infection on long-term survival after potentially curative resection for gastric cancer. Ann Surg Oncol. 2009;16:311–8.

    Article  PubMed  Google Scholar 

  8. Sasako M, Sano T, Yamamoto S, et al. D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer. N Engl J Med. 2008;359:453–62.

    Article  PubMed  CAS  Google Scholar 

  9. Fatouros M, Roukos DH, Arampatzis I, et al. Factors increasing local recurrence in breast-conserving surgery. Expert Rev Anticancer Ther. 2005;5:737–45.

    Article  PubMed  Google Scholar 

  10. Ziogas D, Baltogiannis G, Fatouros M, Roukos DH. Identifying and preventing high-risk gastric cancer individuals with CDH1 mutations. Ann Surg. 2008;247:714–5.

    Article  PubMed  Google Scholar 

  11. Fatouros M, Baltoyiannis G, Roukos DH. The predominant role of surgery in the prevention and new trends in the surgical treatment of women with BRCA1/2 mutations. Ann Surg Oncol. 2008;15:21–33.

    Article  PubMed  Google Scholar 

  12. Roukos DH. Linking contralateral breast cancer with genetics. Radiother Oncol. 2008;86:139–41.

    Article  PubMed  Google Scholar 

  13. Roukos DH. Breast-cancer stromal cells with TP53 mutations. N Engl J Med. 2008;358:1636.

    Article  PubMed  CAS  Google Scholar 

  14. Roukos DH. Genetics and genome-wide association studies: surgery-guided algorithm and promise for future breast cancer personalized surgery. Expert Rev Mol Diagn. 2008;8:587–97.

    Article  PubMed  Google Scholar 

  15. Roukos DH, Lykoudis E, Liakakos T. Genomics and challenges toward personalized breast cancer local control. J Clin Oncol. 2008;26:4360–1.

    Article  PubMed  Google Scholar 

  16. Roukos DH. Personalized cancer diagnostics and therapeutics. Expert Rev Mol Diagn. 2009;9(3):227–9.

    Article  PubMed  Google Scholar 

  17. Roukos DH. Mea Culpa with cancer-targeted therapy: new thinking and new agents design for novel, causal networks-based, personalized biomedicine. Expert Rev Mol Diagn. 2009;9(3):217–21.

    Article  PubMed  Google Scholar 

  18. Roukos DH. Genome-wide association studies: how predictable is a person's cancer risk? Expert Rev Anticancer Ther. 2009;9(4):389–92.

    Article  PubMed  Google Scholar 

  19. Roukos DH. Twenty-one-gene assay: challenges and promises in translating personal genomics and whole-genome scans into personalized treatment of breast cancer. J Clin Oncol. 2009;27(8):1337–8.

    Google Scholar 

  20. Roukos DH. Radiation therapy for breast cancer. N Engl J Med. 2009;360(13):1362.

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Fourth Surgical Department, Aristotle University of Thessaloniki, Thessaloniki, Greece

    Dimitrios Kanellos MD, Manousos-Georgios Pramateftakis MD & Ioannis Kanellos MD

Authors
  1. Dimitrios Kanellos MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Manousos-Georgios Pramateftakis MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ioannis Kanellos MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ioannis Kanellos MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kanellos, D., Pramateftakis, MG. & Kanellos, I. Postoperative Infectious Morbidity for Resectable Gastric Cancer—Searching Robust Predictors of Survival. Ann Surg Oncol 16, 2373–2374 (2009). https://doi.org/10.1245/s10434-009-0515-4

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-009-0515-4

Keywords

Search

Navigation